186 related articles for article (PubMed ID: 28649535)
21. A novel mucopolysaccharidosis type I associated splice site mutation and IDUA splice variants.
Bremer S; Ohlsson A; Brodtkorb E; Rootwelt H; Rootwelt T; Woldseth B; Mørkrid L
Mol Genet Metab; 2011 Nov; 104(3):289-94. PubMed ID: 21831683
[TBL] [Abstract][Full Text] [Related]
22. Mucopolysaccharidosis type I.
Wraith JE; Jones S
Pediatr Endocrinol Rev; 2014 Sep; 12 Suppl 1():102-6. PubMed ID: 25345091
[TBL] [Abstract][Full Text] [Related]
23. Mucopolysaccharidosis type I: Identification and characterization of mutations affecting alpha-L-iduronidase activity.
Lee-Chen GJ; Lin SP; Chen IS; Chang JH; Yang CW; Chin YW
J Formos Med Assoc; 2002 Jun; 101(6):425-8. PubMed ID: 12189649
[TBL] [Abstract][Full Text] [Related]
24. Clinical and Molecular Characterization of Patients with Mucopolysaccharidosis Type I in an Algerian Series.
Tebani A; Zanoutene-Cheriet L; Adjtoutah Z; Abily-Donval L; Brasse-Lagnel C; Laquerrière A; Marret S; Chalabi Benabdellah A; Bekri S
Int J Mol Sci; 2016 May; 17(5):. PubMed ID: 27196898
[TBL] [Abstract][Full Text] [Related]
25. Impaired bone remodeling and its correction by combination therapy in a mouse model of mucopolysaccharidosis-I.
Kuehn SC; Koehne T; Cornils K; Markmann S; Riedel C; Pestka JM; Schweizer M; Baldauf C; Yorgan TA; Krause M; Keller J; Neven M; Breyer S; Stuecker R; Muschol N; Busse B; Braulke T; Fehse B; Amling M; Schinke T
Hum Mol Genet; 2015 Dec; 24(24):7075-86. PubMed ID: 26427607
[TBL] [Abstract][Full Text] [Related]
26. Recombinant alpha-L-iduronidase: characterization of the purified enzyme and correction of mucopolysaccharidosis type I fibroblasts.
Unger EG; Durrant J; Anson DS; Hopwood JJ
Biochem J; 1994 Nov; 304 ( Pt 1)(Pt 1):43-9. PubMed ID: 7998955
[TBL] [Abstract][Full Text] [Related]
27. Treatment of the mouse model of mucopolysaccharidosis I with retrovirally transduced bone marrow.
Zheng Y; Rozengurt N; Ryazantsev S; Kohn DB; Satake N; Neufeld EF
Mol Genet Metab; 2003 Aug; 79(4):233-44. PubMed ID: 12948739
[TBL] [Abstract][Full Text] [Related]
28. Mapping of IDUA gene variants in Pakistani patients with mucopolysaccharidosis type 1.
Zahoor MY; Cheema HA; Ijaz S; Anjum MN; Ramzan K; Bhinder MA
J Pediatr Endocrinol Metab; 2019 Nov; 32(11):1221-1227. PubMed ID: 31473686
[TBL] [Abstract][Full Text] [Related]
29. Murine mucopolysaccharidosis type I: targeted disruption of the murine alpha-L-iduronidase gene.
Clarke LA; Russell CS; Pownall S; Warrington CL; Borowski A; Dimmick JE; Toone J; Jirik FR
Hum Mol Genet; 1997 Apr; 6(4):503-11. PubMed ID: 9097952
[TBL] [Abstract][Full Text] [Related]
30. In vivo adenine base editing corrects newborn murine model of Hurler syndrome.
Su J; Jin X; She K; Liu Y; Song L; Zhao Q; Xiao J; Li R; Deng H; Lu F; Yang Y
Mol Biomed; 2023 Feb; 4(1):6. PubMed ID: 36813914
[TBL] [Abstract][Full Text] [Related]
31. Genotypic and bioinformatic evaluation of the alpha-l-iduronidase gene and protein in patients with mucopolysaccharidosis type I from Colombia, Ecuador and Peru.
Pineda T; Marie S; Gonzalez J; García AL; Acosta A; Morales M; Correa LN; Vivas R; Escobar X; Protzel A; Barba M; Ospina S; Corredor C; Mansilla S; Velasco HM
Mol Genet Metab Rep; 2014; 1():468-473. PubMed ID: 27896125
[TBL] [Abstract][Full Text] [Related]
32. Morphologic description of male reproductive accessory glands in a mouse model of mucopolysaccharidosis type I (MPS I).
do Nascimento CC; Junior OA; D'Almeida V
J Mol Histol; 2020 Apr; 51(2):137-145. PubMed ID: 32162173
[TBL] [Abstract][Full Text] [Related]
33. Morphological damage in Sertoli, myoid and interstitial cells in a mouse model of mucopolysaccharidosis type I (MPS I).
do Nascimento CC; Aguiar O; Viana GM; D'Almeida V
Mol Biol Rep; 2021 Jan; 48(1):363-370. PubMed ID: 33319323
[TBL] [Abstract][Full Text] [Related]
34. Intravenous delivery for treatment of mucopolysaccharidosis type I: A comparison of AAV serotypes 9 and rh10.
Belur LR; Podetz-Pedersen KM; Tran TA; Mesick JA; Singh NM; Riedl M; Vulchanova L; Kozarsky KF; McIvor RS
Mol Genet Metab Rep; 2020 Sep; 24():100604. PubMed ID: 32461912
[TBL] [Abstract][Full Text] [Related]
35. Molecular genetics of mucopolysaccharidosis type I: diagnostic, clinical, and biological implications.
Scott HS; Bunge S; Gal A; Clarke LA; Morris CP; Hopwood JJ
Hum Mutat; 1995; 6(4):288-302. PubMed ID: 8680403
[TBL] [Abstract][Full Text] [Related]
36. Intranasal Adeno-Associated Virus Mediated Gene Delivery and Expression of Human Iduronidase in the Central Nervous System: A Noninvasive and Effective Approach for Prevention of Neurologic Disease in Mucopolysaccharidosis Type I.
Belur LR; Temme A; Podetz-Pedersen KM; Riedl M; Vulchanova L; Robinson N; Hanson LR; Kozarsky KF; Orchard PJ; Frey WH; Low WC; McIvor RS
Hum Gene Ther; 2017 Jul; 28(7):576-587. PubMed ID: 28462595
[TBL] [Abstract][Full Text] [Related]
37. Effect of neonatal administration of a retroviral vector expressing alpha-L-iduronidase upon lysosomal storage in brain and other organs in mucopolysaccharidosis I mice.
Chung S; Ma X; Liu Y; Lee D; Tittiger M; Ponder KP
Mol Genet Metab; 2007 Feb; 90(2):181-92. PubMed ID: 16979922
[TBL] [Abstract][Full Text] [Related]
38. Alpha-L-iduronidase deficiency: A novel mutation resulting in severe early presentation of Mucopolysaccharidosis type I and literature review of the molecular basis.
Al Zaabi NN; Sirajum M; Al-Wawi MZ; Al Suwaiji M
Clin Case Rep; 2022 May; 10(5):e05904. PubMed ID: 35664514
[TBL] [Abstract][Full Text] [Related]
39. Molecular genetic defect underlying alpha-L-iduronidase pseudodeficiency.
Aronovich EL; Pan D; Whitley CB
Am J Hum Genet; 1996 Jan; 58(1):75-85. PubMed ID: 8554071
[TBL] [Abstract][Full Text] [Related]
40. Mucopolysaccharidosis type I: characterization of novel mutations affecting alpha-L-iduronidase activity.
Lee-Chen GJ; Lin SP; Tang YF; Chin YW
Clin Genet; 1999 Jul; 56(1):66-70. PubMed ID: 10466419
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
